GlassScriptPhysician profile
Tyler Reber
NPI 1619499316
$4,418.08
in general payments reported to CMS, 2019-2025
13 companies · $56.83 in 2025
The $56.83 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,657 · 2022: $2,241 · 2023: $310 · 2024: $154 · 2025: $56.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $520.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,654.54 | 2022-2023 | |
| Summit Surgical Corp. | $1,200.00 | 2021 | |
| Impactortho, INC. | $691.60 | 2022 | |
| Orthofix Medical, INC. | $447.49 | 2021-2025 | Physio-Stim |
| Abbvie INC. | $138.34 | 2021-2025 | |
| Averitas Pharma INC. | $72.93 | 2023-2024 | Qutenza |
| Paratek Pharmaceuticals, INC. | $55.47 | 2024-2025 | Nuzyra |
| Bioventus LLC | $48.49 | 2021-2024 | Exogen Ultrasound Bone Healing System |
| Aroa Biosurgery Incorporated | $31.60 | 2023 | |
| Angiodynamics, INC. | $25.57 | 2022 | |
| Abbott Laboratories | $23.15 | 2022 | |
| Smith+Nephew, INC. | $19.95 | 2021 | |
| Advanced Oxygen Therapy INC. | $8.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Reber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.